Company Filing History:
Years Active: 2010-2013
Title: Michael Colin Cramp: Innovator in Therapeutic Compounds
Introduction
Michael Colin Cramp is a notable inventor based in Essex, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of respiratory conditions such as asthma and COPD. With a total of three patents to his name, Cramp's work is recognized for its potential impact on healthcare.
Latest Patents
Among his latest patents is a groundbreaking invention related to quinolines and their therapeutic use. The compounds of formula (I) are identified as CRTH2 ligands, which are useful in treating conditions like asthma and COPD. The detailed specifications outline various chemical structures and substitutions that enhance the efficacy of these compounds in medical applications.
Career Highlights
Throughout his career, Michael Colin Cramp has worked with Pulmagen Therapeutics Limited and Pulmagen Therapeutics (Asthma) Limited. His experience in these companies has allowed him to focus on developing innovative solutions for respiratory diseases. His work has contributed to advancing therapeutic options available to patients.
Collaborations
Cramp has collaborated with notable professionals in his field, including Rosa Arienzo and George Hynd. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic compounds.
Conclusion
Michael Colin Cramp's contributions to the field of therapeutic compounds demonstrate his commitment to innovation in healthcare. His patents and collaborations reflect a dedication to improving treatment options for respiratory conditions.